IL-10 revisited in systemic lupus erythematosus

Area of Science:

• Immunology
• Molecular Biology
• Autoimmune Diseases

Background:

• Interleukin-10 (IL-10) is a pleiotropic cytokine known for immune-suppressive functions.
• IL-10 limits pathogenesis in inflammatory diseases like multiple sclerosis (MS) and Crohn's disease.
• Emerging evidence highlights dual roles for IL-10 in Systemic Lupus Erythematosus (SLE).

Purpose of the Study:

• To elucidate the complex role of IL-10 in Systemic Lupus Erythematosus (SLE).
• To investigate IL-10's function as a driver of B cell responses, particularly plasma cell differentiation.
• To understand IL-10's impact on extrafollicular B cell responses in SLE.

Main Methods:

• Review of current literature on IL-10 function in immunology and autoimmune diseases.
• Analysis of studies investigating IL-10 production by various immune cells, including B cells and T helper subsets.
• Examination of evidence linking IL-10 to B cell proliferation, class switching, and plasma cell differentiation.

Main Results:

• IL-10 inhibits pro-inflammatory effector functions in SLE.
• IL-10 acts as a key driver of the extrafollicular antibody response outside germinal centers (GC).
• IL-10 promotes direct differentiation of activated B cells into plasma cells, bypassing GC-dependent pathways.

Conclusions:

• IL-10 plays a dichotomous role in SLE, suppressing some inflammation while promoting autoreactive antibody production.
• Extrafollicular T helper cells, producing IL-10, support autoreactive plasma cell formation in SLE.
• Understanding IL-10's role is crucial for developing targeted therapies for SLE and related autoimmune conditions.